The Indian pharmaceutical sector opened on a broadly positive note on April 29, 2026. Of the 24 pharma stocks tracked, the majority are trading in the green in early trade on both BSE and NSE. The S&P BSE Healthcare index is up 0.62% at 44,837.34, broadly in line with the Nifty 50 (+0.70% at 24,164.80) and the S&P BSE Sensex (+0.69% at 77,414.58), suggesting the sector is moving with the broader market rather than showing independent strength.
Top Gainers in Pharma Stocks Today (April 29, 2026)
Orchid Pharma leads all pharma gainers with a rise of 3.35% on BSE (603.75, +3.15% on NSE), making it the standout mover in early trade today.
Torrent Pharma is up 1.78% on BSE at ₹4,257.75 (NSE: ₹4,258.90, +1.82%), continuing its position as one of the higher-priced pharma counters on Indian exchanges.
Glenmark Pharma is trading higher by 1.72% on BSE at ₹2,446.35 (NSE: ₹2,448.70, +1.87%), among the better performers in today’s session.
Ajanta Pharma has gained 1.71% on BSE at ₹2,802.10, with a slightly stronger move of +2.14% on NSE at ₹2,815.00.
J.B. Chemicals is up 1.49% on BSE at ₹2,074.00 (NSE: ₹2,073.00, +1.44%).
Strides Pharma Science is trading at ₹1,067.35 on BSE, up 1.41% (NSE: ₹1,067.10, +1.44%).
Natco Pharma has risen 1.36% on BSE to ₹1,109.00 (NSE: ₹1,107.40, +1.22%).
Mid-Range Movers
Mankind Pharma is up 1.06% on BSE at ₹2,294.00 (NSE: ₹2,292.70, +1.25%).
Lupin trades at ₹2,323.50 on BSE, up 0.93% (NSE: ₹2,321.20, +0.80%).
Zydus Lifesciences is up 0.88% on BSE at ₹919.25 (NSE: ₹918.45, +0.78%).
Cipla has gained 0.79% on BSE to ₹1,318.40 (NSE: ₹1,320.30, +1.06%).
Divis Laboratories is up 0.68% on BSE at ₹6,477.95, the highest-priced individual pharma stock in today’s list (NSE: ₹6,478.00, +0.71%).
Biocon is trading at ₹365.10 on BSE, up 0.63% (NSE: ₹364.65, +0.51%).
Sun Pharma, the largest Indian pharmaceutical company by market cap, is up 0.55% at ₹1,757.35 on BSE (NSE: ₹1,758.10, +0.62%).
Wockhardt has gained 0.43% to ₹1,423.20 on BSE (NSE: ₹1,424.10, +0.48%).
Sudeep Pharma is up 0.37% on BSE at ₹686.30 (NSE: ₹685.85, +0.30%).
Panacea Biotech is trading marginally higher at ₹377.85 on BSE, up 0.13% (NSE: ₹378.10, +0.29%).
Indoco Remedies has gained 0.24% on BSE to ₹212.15, though it is flat to slightly negative on NSE at ₹211.30 (-0.07%).
Stocks Trading in the Red Today
A handful of pharma stocks are trading lower in early trade on April 29:
Aurobindo Pharma is down 0.32% on BSE at ₹1,416.75 (NSE: ₹1,415.50, -0.50%).
Dr. Reddy’s Laboratories has slipped 0.39% to ₹1,349.40 on BSE (NSE: ₹1,349.10, -0.41%).
IPCA Laboratories is marginally lower, down 0.24% on BSE at ₹1,535.45 (NSE: ₹1,535.50, -0.10%).
Alembic Pharma is down 0.41% on BSE at ₹756.75 (NSE: ₹755.85, -0.47%).
Aarti Drugs is the only stock with losses on both exchanges in double-digit basis points: down 0.20% on BSE at ₹379.75 (NSE: ₹379.20, -0.07%).
Key Observations — April 29, 2026
Broad-based gains with few exceptions. Of 23 individual pharma stocks in today’s list, 18 are trading higher on BSE as of early trade. Only five — Aarti Drugs, Alembic Pharma, Aurobindo Pharma, Dr. Reddy’s, and IPCA Labs — are in the red, and all by less than 0.50%.
Sector performance is in line with benchmark indices. The S&P BSE Healthcare index (+0.62%) is rising alongside the Sensex (+0.69%) and Nifty 50 (+0.70%). This indicates the pharma sector’s early gains today are largely a reflection of broad market sentiment rather than sector-specific catalysts.
Orchid Pharma is the standout mover. At +3.35% on BSE, its gain is significantly higher than the rest of the pack. Investors should look at stock-specific news or announcements before drawing conclusions from the price movement.
Large-cap pharma stocks are up modestly. Sun Pharma (+0.55%), Cipla (+0.79%), Lupin (+0.93%), and Dr. Reddy’s (-0.39%) are all within a 1% range, consistent with subdued early-session moves on a day with no major sector-specific news visible in this data.
Data source: BSE and NSE as of April 29, 2026 (BSE: 9:47 AM IST / NSE: 9:49 AM IST). This article is for informational purposes only and does not constitute investment advice. Stock prices can change rapidly during market hours. Please verify prices on official BSE/NSE platforms before making any financial decisions.